FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2273287551> ?p ?o ?g. }

• W2273287551 endingPage "115" @default.
• W2273287551 startingPage "109" @default.
• W2273287551 abstract "(177)Lu-ethylenediaminetetramethylene phosphonic acid (EDTMP) is presently suggested as an excellent bone seeking radionuclide for developing metastatic bone pain (MBP) palliation agent owing to its suitable nuclear decay characteristics. To find the exact dosage and its efficiency, this clinical study was performed on the human being, using (177)Lu-EDTMP for MBP palliation. (177)Lu-EDTMP was prepared by Iran, atomic energy organization. Thirty consecutive patients with determined tumors, incontrollable MBP, and positive bone scan at 4 weeks before the beginning of the study participated in this study in the nuclear medicine ward. (177)Lu-EDTMP in the form of sterile slow IV injection was administered with a dose of 29.6 MBq/kg. Short form of brief pain inventory questionnaire was used to evaluate the efficiency of the intervention. Questionnaires were filled out by an expert nuclear physician every 2 weeks while the cell blood count was also checked every 2 weeks up to 12 weeks for evaluation of bone marrow suppression and hematological toxicity. Furthermore, whole body scan was done at days 1, 3, and 7. Twenty-five patients showed a significant pain relief since 2 weeks after the injection, and continued until the end of the follow up period (12 weeks). There were no significant early complications such as bone marrow suppression, hematological toxicity, and no systemic adverse effects. No complication was observed in renal function. Twenty one patients showed flare phenomenon that was started after the 12.2 ± 1.78 h lasting for 38.4 ± 23.08. Sixteen patients (53%) were completely treated; nine patients (30%) showed a partial response, and five patients (17%) had no response to treatment. Total response to treatment was achieved in 25 patients (83%). At the end of the evaluation, no bone marrow suppression or hematologic toxicity was observed. (177)Lu-EDTMP has shown suitable physical and biological properties with good results in long term bone pain relief for patients with bone metastasis." @default.
• W2273287551 created "2016-06-24" @default.
• W2273287551 creator A5010324391 @default.
• W2273287551 creator A5010691273 @default.
• W2273287551 creator A5034667007 @default.
• W2273287551 creator A5083487083 @default.
• W2273287551 creator A5089794273 @default.
• W2273287551 date "2015-04-01" @default.
• W2273287551 modified "2023-09-27" @default.
• W2273287551 title "Metastatic Bone Pain Palliation using 177 Lu-Ethylenediaminetetramethylene Phosphonic Acid" @default.
• W2273287551 cites W1791974027 @default.
• W2273287551 cites W1805060424 @default.
• W2273287551 cites W1898092403 @default.
• W2273287551 cites W1935714962 @default.
• W2273287551 cites W1941793774 @default.
• W2273287551 cites W1942863632 @default.
• W2273287551 cites W1983514189 @default.
• W2273287551 cites W2004836798 @default.
• W2273287551 cites W2008197227 @default.
• W2273287551 cites W2008844534 @default.
• W2273287551 cites W2009671106 @default.
• W2273287551 cites W2010027532 @default.
• W2273287551 cites W2010431558 @default.
• W2273287551 cites W2015773253 @default.
• W2273287551 cites W2016237506 @default.
• W2273287551 cites W2030224343 @default.
• W2273287551 cites W2042634642 @default.
• W2273287551 cites W2058815142 @default.
• W2273287551 cites W2062271329 @default.
• W2273287551 cites W2064382434 @default.
• W2273287551 cites W2087023042 @default.
• W2273287551 cites W2092297304 @default.
• W2273287551 cites W2092681716 @default.
• W2273287551 cites W2106885110 @default.
• W2273287551 cites W2108613323 @default.
• W2273287551 cites W2109360630 @default.
• W2273287551 cites W2125398839 @default.
• W2273287551 cites W2128530877 @default.
• W2273287551 cites W2138217778 @default.
• W2273287551 cites W2237199935 @default.
• W2273287551 cites W2271278148 @default.
• W2273287551 cites W2320909684 @default.
• W2273287551 cites W2330375094 @default.
• W2273287551 cites W2344363502 @default.
• W2273287551 cites W4211125560 @default.
• W2273287551 doi "https://doi.org/10.4103/1450-1147.157124" @default.
• W2273287551 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4455166" @default.
• W2273287551 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26097421" @default.
• W2273287551 hasPublicationYear "2015" @default.
• W2273287551 type Work @default.
• W2273287551 sameAs 2273287551 @default.
• W2273287551 citedByCount "28" @default.
• W2273287551 countsByYear W22732875512015 @default.
• W2273287551 countsByYear W22732875512016 @default.
• W2273287551 countsByYear W22732875512017 @default.
• W2273287551 countsByYear W22732875512018 @default.
• W2273287551 countsByYear W22732875512019 @default.
• W2273287551 countsByYear W22732875512020 @default.
• W2273287551 countsByYear W22732875512021 @default.
• W2273287551 countsByYear W22732875512022 @default.
• W2273287551 countsByYear W22732875512023 @default.
• W2273287551 crossrefType "journal-article" @default.
• W2273287551 hasAuthorship W2273287551A5010324391 @default.
• W2273287551 hasAuthorship W2273287551A5010691273 @default.
• W2273287551 hasAuthorship W2273287551A5034667007 @default.
• W2273287551 hasAuthorship W2273287551A5083487083 @default.
• W2273287551 hasAuthorship W2273287551A5089794273 @default.
• W2273287551 hasBestOaLocation W22732875511 @default.
• W2273287551 hasConcept C126322002 @default.
• W2273287551 hasConcept C141071460 @default.
• W2273287551 hasConcept C197934379 @default.
• W2273287551 hasConcept C2776139714 @default.
• W2273287551 hasConcept C2780007613 @default.
• W2273287551 hasConcept C29730261 @default.
• W2273287551 hasConcept C2989005 @default.
• W2273287551 hasConcept C71924100 @default.
• W2273287551 hasConcept C81182388 @default.
• W2273287551 hasConceptScore W2273287551C126322002 @default.
• W2273287551 hasConceptScore W2273287551C141071460 @default.
• W2273287551 hasConceptScore W2273287551C197934379 @default.
• W2273287551 hasConceptScore W2273287551C2776139714 @default.
• W2273287551 hasConceptScore W2273287551C2780007613 @default.
• W2273287551 hasConceptScore W2273287551C29730261 @default.
• W2273287551 hasConceptScore W2273287551C2989005 @default.
• W2273287551 hasConceptScore W2273287551C71924100 @default.
• W2273287551 hasConceptScore W2273287551C81182388 @default.
• W2273287551 hasIssue "02" @default.
• W2273287551 hasLocation W22732875511 @default.
• W2273287551 hasLocation W22732875512 @default.
• W2273287551 hasLocation W22732875513 @default.
• W2273287551 hasLocation W22732875514 @default.
• W2273287551 hasLocation W22732875515 @default.
• W2273287551 hasOpenAccess W2273287551 @default.
• W2273287551 hasPrimaryLocation W22732875511 @default.
• W2273287551 hasRelatedWork W1586374228 @default.
• W2273287551 hasRelatedWork W2003938723 @default.
• W2273287551 hasRelatedWork W2047967234 @default.
• W2273287551 hasRelatedWork W2118496982 @default.

• next